Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases

由 Pirillo, Angela, Catapano, Alberico Luigi
出版 2013

Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3

由 Pirillo, Angela, Catapano, Alberico Luigi
發表在 Drug Des Devel Ther (2015)

Molecular Mechanisms Responsible for the Antiinflammatory and Protective Effect of HDL on the Endothelium

由 Norata, Giuseppe D, Catapano, Alberico L
出版 2005

Adherence to lipid-lowering treatment: the patient perspective

由 Casula, Manuela, Tragni, Elena, Catapano, Alberico Luigi
出版 2012

Multifactorial Activation of NLRP3 Inflammasome: Relevance for a Precision Approach to Atherosclerotic Cardiovascular Risk and Disease

由 Baragetti, Andrea, Catapano, Alberico Luigi, Magni, Paolo
發表在 Int J Mol Sci (2020)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins

由 Grigore, Liliana, Norata, Giuseppe Danilo, Catapano, Alberico L
出版 2008

High density lipoproteins and atherosclerosis: emerging aspects

由 Sala, Federica, Catapano, Alberico Luigi, Norata, Giuseppe Danilo
出版 2012

LOX-1, OxLDL, and Atherosclerosis

由 Pirillo, Angela, Norata, Giuseppe Danilo, Catapano, Alberico Luigi
出版 2013

Novel concepts in HDL pharmacology

由 Remaley, Alan T., Norata, Giuseppe D., Catapano, Alberico L.
出版 2014

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives

由 Catapano, Alberico Luigi, Pirillo, Angela, Norata, Giuseppe Danilo
發表在 Vasc Health Risk Manag (2017)

Vascular inflammation and low‐density lipoproteins: is cholesterol the link? A lesson from the clinical trials

由 Catapano, Alberico Luigi, Pirillo, Angela, Norata, Giuseppe Danilo
發表在 Br J Pharmacol (2017)

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?

由 Catapano, Alberico Luigi, Pirillo, Angela, Norata, Giuseppe Danilo
發表在 Mol Ther (2017)

The CD1d-Natural Killer T Cell Axis in Atherosclerosis

由 Bondarenko, Sergey, Catapano, Alberico Luigi, Norata, Giuseppe Danilo
發表在 J Innate Immun (2014)

New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs

由 Norata, Giuseppe Danilo, Ballantyne, Christie M., Catapano, Alberico Luigi
出版 2013

Current guidelines on prevention with a focus on dyslipidemias

由 Graham, Ian M., Catapano, Alberico L., Wong, Nathan D.
發表在 Cardiovasc Diagn Ther (2017)

Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases

由 Bonacina, Fabrizia, Baragetti, Andrea, Catapano, Alberico Luigi, Norata, Giuseppe Danilo
出版 2013

Effect of Lipids and Lipoproteins on Hematopoietic Cell Metabolism and Commitment in Atherosclerosis

由 Baragetti, Andrea, Bonacina, Fabrizia, Catapano, Alberico Luigi, Norata, Giuseppe Danilo
發表在 Immunometabolism (2021)

HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases

由 Bonacina, Fabrizia, Pirillo, Angela, Catapano, Alberico L., Norata, Giuseppe D.
發表在 Cells (2021)

MicroRNAs and lipoproteins: a connection beyond atherosclerosis?

由 Norata, Giuseppe Danilo, Sala, Federica, Catapano, Alberico Luigi, Fernández-Hernando, Carlos
出版 2012

Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering

由 Norata, Giuseppe Danilo, Tavori, Hagai, Pirillo, Angela, Fazio, Sergio, Catapano, Alberico L.
發表在 Cardiovasc Res (2016)